Towards the molecular characterization of the stable producer phenotype of recombinant antibody-producing NS0 myeloma cells
- 103 Downloads
The loss of heterologous protein expression is one of the major problems faced by industrial cell line developers and has been reported by several authors. Therefore, the understanding of the mechanisms involved in the generation of stable and high producer cell lines is a critical issue, especially for those processes based on long term continuous cultures. We characterized two recombinant NS0 myeloma cell lines expressing Nimotuzumab, a humanized anti-human epidermal growth factor receptor (EGFR) antibody. The hR3/H7 clone is a stable producer obtained from the unstable hR3/t16 clone. The unstable clone was characterized by a bimodal distribution of intracellular immunoglobulin staining using flow cytometry. Loss of antibody production was due to the emergence of a non-producer cell subpopulation that increased with cell generation number. Immunoglobulin heavy chain (HC) and light chain (LC) ratio (HC/LC) was lower for the unstable phenotype. Proteomic maps using two dimensional gel electrophoresis (2DE) were obtained for both clones, at initial cell culture time and after 40 generations. Fifteen proteins potentially associated with the phenomenon of production stability were identified. The hR3/H7 stable clone showed an up-regulated expression pattern for most of these proteins. The regulation of recombinant antibody production by the host NS0 myeloma cell line most likely involves simultaneously cellular processes such as DNA transcription, mRNA processing, protein synthesis and folding, vesicular transport, glycolysis and energy production, according to the proteins identified in the present proteomic study.
KeywordsRecombinant antibody Protein expression stability NS0 myeloma cell line Proteomics
We thank Dr. Yassel Ramos Gómez from the Center of Genetic Engineering and Biotechnology (CIGB, Havana, Cuba) for his valuable help in the proteomics assays and Dr. Alejandro López-Requena for a careful reading of the manuscript.
- Castillo A, Victores S, Faife E, Rabasa Y, de la Luz KR (2005) Development of an integrated strategy for recombinant cell line selection. In: Gódia F, Fussenegger M (ed) Animal cell technology meets genomics. Springer, Berlin, pp 505–507Google Scholar
- Chevalier S, MacDonald N, Tonge R, Rayner S, Rowlinson R, Shaw J, Young J, Davison M, Roberts R (2000) Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferators nafenopin. Eur J Biochem 267:4624–4634CrossRefGoogle Scholar
- de la Luz KR, Rojas L, Victores S, Lage A, Eyers C, Hart S, Castellanos L, Castillo A, Gaskell S (2008) Proteomic analysis of the adaptation of the host NS0 myeloma cell line to a protein-free medium. Biotecnología Aplicada 24:215–223Google Scholar
- Faife E, Rodríguez T, Rabaza Y, Badía T, Victores S, Castillo A (2008) Effects of selection and adaptation of NS0 cells to protein-free medium on the properties, affinity and biological activity of a monoclonal antibody. Biotecnología Aplicada 25:247–253Google Scholar
- Martínez A, Mulshine JL (2002) Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) as a marker of preinvasive lung cancer. J Clin Ligand Assay 25:100–103Google Scholar
- Piskunova TS, Yurova MN, Ovsyannikov AI, Semenchenko AV, Zabezhinski MA, Popovich IG, Wang ZQ, Anisimov VN (2008) Deficiency in poly (ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice. Curr Gerontol Geriatr Res 754190. Epub Apr 14. PMID: 19415146Google Scholar
- Rojas LE, de la Luz KR, Victores S, Castellanos L, Gaskell S, Castillo A, Pérez R (2005) Comparative proteomic study of mechanisms involved in the expression of recombinant monoclonal antibody in non amplified NS0 myeloma cell line. In: Smith R (ed) Cell technology for cell products. Springer Publisher, Berlin, pp 715–721Google Scholar
- Voet D, Voet JG (1995) Translation. In: Rose N (ed) Biochemistry, second edition. Wiley, New York, pp 997–1003Google Scholar
- Whitford W (2003) NS0 serum-free culture and applications. BioProcess Int 12:36–47Google Scholar